Get The Start-Up Israel's Daily Start-Up by email and never miss our top stories Israeli bio-tech firm ElMindA have developed the world's first FDA approved brain assessment tool, which can visualise trauma and illnesses by creating a three dimensional image of neural pathways. The new tool is designed to help doctors diagnose patients with neurological disorders such as epilepsy or Parkinson's disease.
Israeli bio-tech firm ElMindA have developed the world's first FDA approved brain assessment tool, which can visualise trauma and illnesses by creating a three dimensional image of neural pathways. The new tool is designed to help doctors diagnose patients with neurological disorders such as epilepsy or Parkinson's disease.